|
|
|
|
| LEADER |
02830nam a2200313 a 4500 |
| 001 |
1886134 |
| 005 |
20171111234711.0 |
| 008 |
000807s1993 dcu ob 000 0 eng d |
| 020 |
|
|
|a 0585155283
|q (electronic bk.)
|
| 020 |
|
|
|a 9780585155289
|q (electronic bk.)
|z 030904989X
|q (pbk.)
|q (pbk.)
|
| 040 |
|
|
|a N$T
|b eng
|e pn
|z 9780309049894
|
| 050 |
|
4 |
|a RA564.85
|b .I57 1993eb
|
| 245 |
0 |
3 |
|a An assessment of the NIH Women's Health Initiative /
|c Committee to Review the NIH Women's Health Initiative, Food and Nutrition Board, and Board on Health Sciences Policy, Institute of Medicine ; Susan Thaul and Dana Hotra, editors.
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academy Press,
|c 1993.
|
| 300 |
|
|
|a 1 online resource (xv, 142 pages)
|
| 504 |
|
|
|a Includes bibliographical references (pages 91-93).
|
| 505 |
0 |
|
|a (cont) Threats to completion of HRT branch -- Use of HRT in elderly women -- Calcium and vitamin D supplement branch -- Rationale -- Design and methods -- Threats to successful completion of CaD branch -- Clinical trial cost -- Data available to committee deliberations -- WHI cost relative to other larger studies -- Clinical center funding -- Total cost -- Potential causes of budget shortfalls -- Observational study -- Rationale -- Design and method -- Cost -- Recommendations -- Community prevention study -- Rationale -- Design and methods -- Cost -- Recommendations -- Concluding remarks -- Response to the statement of task -- Societal context -- Efficacy and effectiveness -- Public health choice versus individual choice -- Considerations beyond science -- Clinical trial exclusion criteria -- U.S. House of Representatives Appropriations Committee -- Statement of task -- Documents received by the Institute of Medicine from the National Institutes of Health -- Meeting participants June, July and August 1993 -- Primary and subsidiary hypotheses of the women's health initiative clinical trial.
|
| 505 |
0 |
|
|a (cont) Women's health initiative committees -- NIH-sponsored women's health studies -- NIH cost and FTE summary for Vanguard clinical centers -- NIH power calculations -- Women's health initiative clinical coordinating center and Vanguard clinical centers principal investigators -- Abbreviations and acronyms -- Committee and staff biographies.
|
| 650 |
|
0 |
|a Women
|x Health and hygiene
|z United States.
|
| 650 |
|
2 |
|a Women's Health.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Women's Health.
|
| 650 |
|
7 |
|a Women
|x Health and hygiene.
|
| 651 |
|
2 |
|a United States.
|
| 651 |
|
7 |
|a United States.
|
| 700 |
1 |
|
|a Thaul, Susan.
|
| 700 |
1 |
|
|a Hotra, Dana.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee to Review the NIH Women's Health Initiative.
|
| 856 |
4 |
0 |
|u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=14118
|
| 952 |
|
|
|a CY-NiOUC
|b 5a0463656c5ad14ac1ee94c7
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
